Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pyronaridine-artesunate efficacy study for uncomplicated falciparum and vivax malaria in Lao PDR
ACTRN12618001348246Phase 4Not yet recruiting
- Sponsor
- Ministry of Health
- Start
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of artesunate + pyronaridine and primaquine in Malaria and malaria, sponsored by Ministry of Health. Primary endpoints: Efficacy of pyronaridine-artesunate with low-dose primaquine and Differentiate recrudescence from new infection. Planned start Aug 2018; status: not yet recruiting.
02
Drugs
artesunate + pyronaridineprimaquine
03
Conditions
Malariamalaria
Beyond the preview
Go deeper on ACTRN12618001348246.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618001348246.